Loading…
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
The system L amino acid transporter (LAT) has an important role in the transport of various amino acids, and there have been reports about the relation of this system to cancer. Although LATs are highly expressed in the kidneys, little is known about their influence on human renal cancer. To clarify...
Saved in:
Published in: | BMC cancer 2013-10, Vol.13 (1), p.509-509, Article 509 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3 |
---|---|
cites | cdi_FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3 |
container_end_page | 509 |
container_issue | 1 |
container_start_page | 509 |
container_title | BMC cancer |
container_volume | 13 |
creator | Betsunoh, Hironori Fukuda, Takehiko Anzai, Naohiko Nishihara, Daisaku Mizuno, Tomoya Yuki, Hideo Masuda, Akinori Yamaguchi, Yoshiyuki Abe, Hideyuki Yashi, Masahiro Fukabori, Yoshitatsu Yoshida, Ken-Ichiro Kamai, Takao |
description | The system L amino acid transporter (LAT) has an important role in the transport of various amino acids, and there have been reports about the relation of this system to cancer. Although LATs are highly expressed in the kidneys, little is known about their influence on human renal cancer.
To clarify the role of LATs in human clear cell renal cell carcinoma (RCC), we investigated the expression of mRNAs for LAT1, LAT2, LAT3, LAT4, and 4F2hc in clear cell RCC tissues. The mRNAs of these five genes were analyzed by the real-time reverse transcription polymerase chain reaction in matched sets of tumor and non-tumor tissues obtained at operation from 82 Japanese patients with clear cell RCC. We also measured phosphorylated S6 ribosomal protein (Ser-235/236) proteins levels in 18 paired tumor and non-tumor tissues of the patients by Western blotting.
Expression of LAT1 mRNA was significantly increased in tumor tissue compared with non-tumor tissue, while expression of LAT2 and LAT3 mRNAs was reduced. There was no difference in the expression of LAT4 and 4F2hc mRNAs between tumor and non-tumor tissues. Increased expression of LAT1 mRNA was associated with less differentiated tumors, local invasion, microscopic vascular invasion, and metastasis. Kaplan-Meier survival analysis showed that a higher serum LAT1 mRNA level was associated with a shorter overall survival time. Phosphorylated S6 ribosomal protein levels were associated with metastatic potential. LAT1 mRNA levels positively correlated with phosphorylated S6 ribosomal protein proteins levels in primary tumors.
These findings suggest that LAT1 mRNA is related to the invasive and progressive potential of clear cell RCC. |
doi_str_mv | 10.1186/1471-2407-13-509 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3832879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534612589</galeid><sourcerecordid>A534612589</sourcerecordid><originalsourceid>FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3</originalsourceid><addsrcrecordid>eNp1k01v1DAQhiMEoqVw54QsIaH2kGLHm8S5IK1WfKy0AqmUszVxJruuEnuxnaX9WfxDHLYsG1SUgy3P877jmXGS5CWjl4yJ4i2blSzNZrRMGU9zWj1KTg9Hj4_2J8kz728oZaWg4mlyks1YIRijp8nPpVEOwWND8Hbr0HttDbEt8Xc-YE86cGsk0GtjCSjdkODA-K11AR05X82vL1JG-qvPc6I9Ae-t0hCi2Q8dNkSbHXi9Q7K1AU3Q0BEwDRlMCzvroO5ixNm1sT6KY87N0IMhqkNwRGHXEYcman5vFTgVL9HD8-RJC53HF_frWfLtw_vrxad09eXjcjFfpXXBipCigEpVuQIsIFZaCqEEIFWKi1xQWqm8VkiRl5gBb6qaspZXvJoVrGrKWab4WfJu77sd6h4bFQtw0Mmt0z24O2lBy2nE6I1c253kgmeirKLBYm9Qa_sfg2lE2V6OI5PjyCTjMk40upzfX8PZ7wP6IHvtx46AQTv4KKhoUUUVjejrf9AbO7jYwZHKq3IEs7_UGjqU2rQ2JlejqZznPNaf5WJMe_kAFb8Ge62swVbH84ngYiKITMDbsIbBe7n8ejVl3xyxG4QubLzthhDfnp-CdA8qZ7132B66x6gc_4CH-vXqeGwHwZ8nz38BpTcBsQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1459790692</pqid></control><display><type>article</type><title>Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central (Training)</source><creator>Betsunoh, Hironori ; Fukuda, Takehiko ; Anzai, Naohiko ; Nishihara, Daisaku ; Mizuno, Tomoya ; Yuki, Hideo ; Masuda, Akinori ; Yamaguchi, Yoshiyuki ; Abe, Hideyuki ; Yashi, Masahiro ; Fukabori, Yoshitatsu ; Yoshida, Ken-Ichiro ; Kamai, Takao</creator><creatorcontrib>Betsunoh, Hironori ; Fukuda, Takehiko ; Anzai, Naohiko ; Nishihara, Daisaku ; Mizuno, Tomoya ; Yuki, Hideo ; Masuda, Akinori ; Yamaguchi, Yoshiyuki ; Abe, Hideyuki ; Yashi, Masahiro ; Fukabori, Yoshitatsu ; Yoshida, Ken-Ichiro ; Kamai, Takao</creatorcontrib><description>The system L amino acid transporter (LAT) has an important role in the transport of various amino acids, and there have been reports about the relation of this system to cancer. Although LATs are highly expressed in the kidneys, little is known about their influence on human renal cancer.
To clarify the role of LATs in human clear cell renal cell carcinoma (RCC), we investigated the expression of mRNAs for LAT1, LAT2, LAT3, LAT4, and 4F2hc in clear cell RCC tissues. The mRNAs of these five genes were analyzed by the real-time reverse transcription polymerase chain reaction in matched sets of tumor and non-tumor tissues obtained at operation from 82 Japanese patients with clear cell RCC. We also measured phosphorylated S6 ribosomal protein (Ser-235/236) proteins levels in 18 paired tumor and non-tumor tissues of the patients by Western blotting.
Expression of LAT1 mRNA was significantly increased in tumor tissue compared with non-tumor tissue, while expression of LAT2 and LAT3 mRNAs was reduced. There was no difference in the expression of LAT4 and 4F2hc mRNAs between tumor and non-tumor tissues. Increased expression of LAT1 mRNA was associated with less differentiated tumors, local invasion, microscopic vascular invasion, and metastasis. Kaplan-Meier survival analysis showed that a higher serum LAT1 mRNA level was associated with a shorter overall survival time. Phosphorylated S6 ribosomal protein levels were associated with metastatic potential. LAT1 mRNA levels positively correlated with phosphorylated S6 ribosomal protein proteins levels in primary tumors.
These findings suggest that LAT1 mRNA is related to the invasive and progressive potential of clear cell RCC.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/1471-2407-13-509</identifier><identifier>PMID: 24168110</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Amino acids ; Analysis ; Cancer ; Carcinoma, Renal cell ; Carcinoma, Renal Cell - genetics ; Carcinoma, Renal Cell - mortality ; Carcinoma, Renal Cell - pathology ; Carrier proteins ; Diagnosis ; Female ; Follow-Up Studies ; Gene Expression ; Health aspects ; Humans ; Kidney Neoplasms - genetics ; Kidney Neoplasms - mortality ; Kidney Neoplasms - pathology ; Large Neutral Amino Acid-Transporter 1 - genetics ; Male ; Messenger RNA ; Metastasis ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Staging ; Patients ; Phosphorylation ; Prognosis ; Proteins ; Ribosomal Protein S6 - metabolism ; RNA, Messenger - genetics ; Rodents ; Tumors</subject><ispartof>BMC cancer, 2013-10, Vol.13 (1), p.509-509, Article 509</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>2013 Betsunoh et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Betsunoh et al.; licensee BioMed Central Ltd. 2013 Betsunoh et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3</citedby><cites>FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832879/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1459790692?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24168110$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Betsunoh, Hironori</creatorcontrib><creatorcontrib>Fukuda, Takehiko</creatorcontrib><creatorcontrib>Anzai, Naohiko</creatorcontrib><creatorcontrib>Nishihara, Daisaku</creatorcontrib><creatorcontrib>Mizuno, Tomoya</creatorcontrib><creatorcontrib>Yuki, Hideo</creatorcontrib><creatorcontrib>Masuda, Akinori</creatorcontrib><creatorcontrib>Yamaguchi, Yoshiyuki</creatorcontrib><creatorcontrib>Abe, Hideyuki</creatorcontrib><creatorcontrib>Yashi, Masahiro</creatorcontrib><creatorcontrib>Fukabori, Yoshitatsu</creatorcontrib><creatorcontrib>Yoshida, Ken-Ichiro</creatorcontrib><creatorcontrib>Kamai, Takao</creatorcontrib><title>Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma</title><title>BMC cancer</title><addtitle>BMC Cancer</addtitle><description>The system L amino acid transporter (LAT) has an important role in the transport of various amino acids, and there have been reports about the relation of this system to cancer. Although LATs are highly expressed in the kidneys, little is known about their influence on human renal cancer.
To clarify the role of LATs in human clear cell renal cell carcinoma (RCC), we investigated the expression of mRNAs for LAT1, LAT2, LAT3, LAT4, and 4F2hc in clear cell RCC tissues. The mRNAs of these five genes were analyzed by the real-time reverse transcription polymerase chain reaction in matched sets of tumor and non-tumor tissues obtained at operation from 82 Japanese patients with clear cell RCC. We also measured phosphorylated S6 ribosomal protein (Ser-235/236) proteins levels in 18 paired tumor and non-tumor tissues of the patients by Western blotting.
Expression of LAT1 mRNA was significantly increased in tumor tissue compared with non-tumor tissue, while expression of LAT2 and LAT3 mRNAs was reduced. There was no difference in the expression of LAT4 and 4F2hc mRNAs between tumor and non-tumor tissues. Increased expression of LAT1 mRNA was associated with less differentiated tumors, local invasion, microscopic vascular invasion, and metastasis. Kaplan-Meier survival analysis showed that a higher serum LAT1 mRNA level was associated with a shorter overall survival time. Phosphorylated S6 ribosomal protein levels were associated with metastatic potential. LAT1 mRNA levels positively correlated with phosphorylated S6 ribosomal protein proteins levels in primary tumors.
These findings suggest that LAT1 mRNA is related to the invasive and progressive potential of clear cell RCC.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amino acids</subject><subject>Analysis</subject><subject>Cancer</subject><subject>Carcinoma, Renal cell</subject><subject>Carcinoma, Renal Cell - genetics</subject><subject>Carcinoma, Renal Cell - mortality</subject><subject>Carcinoma, Renal Cell - pathology</subject><subject>Carrier proteins</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gene Expression</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Kidney Neoplasms - genetics</subject><subject>Kidney Neoplasms - mortality</subject><subject>Kidney Neoplasms - pathology</subject><subject>Large Neutral Amino Acid-Transporter 1 - genetics</subject><subject>Male</subject><subject>Messenger RNA</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Staging</subject><subject>Patients</subject><subject>Phosphorylation</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Ribosomal Protein S6 - metabolism</subject><subject>RNA, Messenger - genetics</subject><subject>Rodents</subject><subject>Tumors</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1k01v1DAQhiMEoqVw54QsIaH2kGLHm8S5IK1WfKy0AqmUszVxJruuEnuxnaX9WfxDHLYsG1SUgy3P877jmXGS5CWjl4yJ4i2blSzNZrRMGU9zWj1KTg9Hj4_2J8kz728oZaWg4mlyks1YIRijp8nPpVEOwWND8Hbr0HttDbEt8Xc-YE86cGsk0GtjCSjdkODA-K11AR05X82vL1JG-qvPc6I9Ae-t0hCi2Q8dNkSbHXi9Q7K1AU3Q0BEwDRlMCzvroO5ixNm1sT6KY87N0IMhqkNwRGHXEYcman5vFTgVL9HD8-RJC53HF_frWfLtw_vrxad09eXjcjFfpXXBipCigEpVuQIsIFZaCqEEIFWKi1xQWqm8VkiRl5gBb6qaspZXvJoVrGrKWab4WfJu77sd6h4bFQtw0Mmt0z24O2lBy2nE6I1c253kgmeirKLBYm9Qa_sfg2lE2V6OI5PjyCTjMk40upzfX8PZ7wP6IHvtx46AQTv4KKhoUUUVjejrf9AbO7jYwZHKq3IEs7_UGjqU2rQ2JlejqZznPNaf5WJMe_kAFb8Ge62swVbH84ngYiKITMDbsIbBe7n8ejVl3xyxG4QubLzthhDfnp-CdA8qZ7132B66x6gc_4CH-vXqeGwHwZ8nz38BpTcBsQ</recordid><startdate>20131030</startdate><enddate>20131030</enddate><creator>Betsunoh, Hironori</creator><creator>Fukuda, Takehiko</creator><creator>Anzai, Naohiko</creator><creator>Nishihara, Daisaku</creator><creator>Mizuno, Tomoya</creator><creator>Yuki, Hideo</creator><creator>Masuda, Akinori</creator><creator>Yamaguchi, Yoshiyuki</creator><creator>Abe, Hideyuki</creator><creator>Yashi, Masahiro</creator><creator>Fukabori, Yoshitatsu</creator><creator>Yoshida, Ken-Ichiro</creator><creator>Kamai, Takao</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131030</creationdate><title>Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma</title><author>Betsunoh, Hironori ; Fukuda, Takehiko ; Anzai, Naohiko ; Nishihara, Daisaku ; Mizuno, Tomoya ; Yuki, Hideo ; Masuda, Akinori ; Yamaguchi, Yoshiyuki ; Abe, Hideyuki ; Yashi, Masahiro ; Fukabori, Yoshitatsu ; Yoshida, Ken-Ichiro ; Kamai, Takao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amino acids</topic><topic>Analysis</topic><topic>Cancer</topic><topic>Carcinoma, Renal cell</topic><topic>Carcinoma, Renal Cell - genetics</topic><topic>Carcinoma, Renal Cell - mortality</topic><topic>Carcinoma, Renal Cell - pathology</topic><topic>Carrier proteins</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gene Expression</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Kidney Neoplasms - genetics</topic><topic>Kidney Neoplasms - mortality</topic><topic>Kidney Neoplasms - pathology</topic><topic>Large Neutral Amino Acid-Transporter 1 - genetics</topic><topic>Male</topic><topic>Messenger RNA</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Staging</topic><topic>Patients</topic><topic>Phosphorylation</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Ribosomal Protein S6 - metabolism</topic><topic>RNA, Messenger - genetics</topic><topic>Rodents</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Betsunoh, Hironori</creatorcontrib><creatorcontrib>Fukuda, Takehiko</creatorcontrib><creatorcontrib>Anzai, Naohiko</creatorcontrib><creatorcontrib>Nishihara, Daisaku</creatorcontrib><creatorcontrib>Mizuno, Tomoya</creatorcontrib><creatorcontrib>Yuki, Hideo</creatorcontrib><creatorcontrib>Masuda, Akinori</creatorcontrib><creatorcontrib>Yamaguchi, Yoshiyuki</creatorcontrib><creatorcontrib>Abe, Hideyuki</creatorcontrib><creatorcontrib>Yashi, Masahiro</creatorcontrib><creatorcontrib>Fukabori, Yoshitatsu</creatorcontrib><creatorcontrib>Yoshida, Ken-Ichiro</creatorcontrib><creatorcontrib>Kamai, Takao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Betsunoh, Hironori</au><au>Fukuda, Takehiko</au><au>Anzai, Naohiko</au><au>Nishihara, Daisaku</au><au>Mizuno, Tomoya</au><au>Yuki, Hideo</au><au>Masuda, Akinori</au><au>Yamaguchi, Yoshiyuki</au><au>Abe, Hideyuki</au><au>Yashi, Masahiro</au><au>Fukabori, Yoshitatsu</au><au>Yoshida, Ken-Ichiro</au><au>Kamai, Takao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma</atitle><jtitle>BMC cancer</jtitle><addtitle>BMC Cancer</addtitle><date>2013-10-30</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>509</spage><epage>509</epage><pages>509-509</pages><artnum>509</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>The system L amino acid transporter (LAT) has an important role in the transport of various amino acids, and there have been reports about the relation of this system to cancer. Although LATs are highly expressed in the kidneys, little is known about their influence on human renal cancer.
To clarify the role of LATs in human clear cell renal cell carcinoma (RCC), we investigated the expression of mRNAs for LAT1, LAT2, LAT3, LAT4, and 4F2hc in clear cell RCC tissues. The mRNAs of these five genes were analyzed by the real-time reverse transcription polymerase chain reaction in matched sets of tumor and non-tumor tissues obtained at operation from 82 Japanese patients with clear cell RCC. We also measured phosphorylated S6 ribosomal protein (Ser-235/236) proteins levels in 18 paired tumor and non-tumor tissues of the patients by Western blotting.
Expression of LAT1 mRNA was significantly increased in tumor tissue compared with non-tumor tissue, while expression of LAT2 and LAT3 mRNAs was reduced. There was no difference in the expression of LAT4 and 4F2hc mRNAs between tumor and non-tumor tissues. Increased expression of LAT1 mRNA was associated with less differentiated tumors, local invasion, microscopic vascular invasion, and metastasis. Kaplan-Meier survival analysis showed that a higher serum LAT1 mRNA level was associated with a shorter overall survival time. Phosphorylated S6 ribosomal protein levels were associated with metastatic potential. LAT1 mRNA levels positively correlated with phosphorylated S6 ribosomal protein proteins levels in primary tumors.
These findings suggest that LAT1 mRNA is related to the invasive and progressive potential of clear cell RCC.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24168110</pmid><doi>10.1186/1471-2407-13-509</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2407 |
ispartof | BMC cancer, 2013-10, Vol.13 (1), p.509-509, Article 509 |
issn | 1471-2407 1471-2407 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3832879 |
source | Publicly Available Content (ProQuest); PubMed Central (Training) |
subjects | Adult Aged Aged, 80 and over Amino acids Analysis Cancer Carcinoma, Renal cell Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - pathology Carrier proteins Diagnosis Female Follow-Up Studies Gene Expression Health aspects Humans Kidney Neoplasms - genetics Kidney Neoplasms - mortality Kidney Neoplasms - pathology Large Neutral Amino Acid-Transporter 1 - genetics Male Messenger RNA Metastasis Middle Aged Neoplasm Grading Neoplasm Invasiveness Neoplasm Metastasis Neoplasm Staging Patients Phosphorylation Prognosis Proteins Ribosomal Protein S6 - metabolism RNA, Messenger - genetics Rodents Tumors |
title | Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A27%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20expression%20of%20system%20large%20amino%20acid%20transporter%20(LAT)-1%20mRNA%20is%20associated%20with%20invasive%20potential%20and%20unfavorable%20prognosis%20of%20human%20clear%20cell%20renal%20cell%20carcinoma&rft.jtitle=BMC%20cancer&rft.au=Betsunoh,%20Hironori&rft.date=2013-10-30&rft.volume=13&rft.issue=1&rft.spage=509&rft.epage=509&rft.pages=509-509&rft.artnum=509&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/1471-2407-13-509&rft_dat=%3Cgale_pubme%3EA534612589%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b616t-e8a9c95cae6a110788c8ae0cc3858009c5bce0e37e2a3d9b01f39394619d742c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1459790692&rft_id=info:pmid/24168110&rft_galeid=A534612589&rfr_iscdi=true |